Lisdexamfetamine

Lisdexamfetamine is a prescription stimulant taken by mouth, once a day. In the United States it is sold as generic lisdexamfetamine dimesylate and under the brand name Vyvanse. It is approved to treat attention deficit hyperactivity disorder (ADHD) in adults and children aged 6 and older, and moderate to severe binge eating disorder in adults.

It is also a Schedule II controlled substance, the same federal tier as oxycodone and methylphenidate. That single fact shapes almost everything practical about it: how a prescription is written, how often it can be filled, which telehealth programs will touch it, and what you pay at the counter. This page explains what the official label says in everyday language, then covers the parts the label does not: real self-pay cost, supply problems, and how prescribing programs differ.

What lisdexamfetamine is and who takes it

Lisdexamfetamine belongs to the amphetamine family of central nervous system stimulants. It is a prodrug, which means the capsule you swallow is not active on its own. Your body has to convert it before it does anything. Enzymes in red blood cells strip off an attached amino acid, l-lysine, and release dextroamphetamine, the active stimulant.

That conversion step is the whole design idea. Because the release depends on the body rather than on the stomach or a coating, the active drug appears gradually and lasts across the day from a single morning dose. A concise clinical description of the capsule is available from a major academic hospital, Cleveland Clinic drug information.

People prescribed this medication usually fall into three groups: children and teens with diagnosed ADHD, adults with ADHD who need coverage through a work or study day, and adults with moderate to severe binge eating disorder. A prodrug is not the same as a harmless drug. The active ingredient is still an amphetamine, still controlled, and still carries a boxed warning. If you are comparing it against other options, our Medication Reference Index covers other commonly prescribed molecules in plain language.

How it works, and what it is approved to treat

Once converted, dextroamphetamine increases the activity of two brain chemicals, dopamine and norepinephrine, in the parts of the brain that handle attention, motivation and impulse control. It does this by pushing more of those chemicals into the space between nerve cells and slowing their reuptake. In plain terms, signals that normally fade too fast stay switched on longer.

ADHD in adults and children aged 6 and older

ADHD is the main approved use. Trials have measured improvements in attention, hyperactivity and impulsive behaviour across child, adolescent and adult groups. A published review of the clinical evidence, hosted at the National Library of Medicine archive, describes the medication as effective and generally well tolerated in those populations. Medication is one part of care. National guidance treats behavioural therapy, school or workplace support, and parent training as part of the same plan, as summarised in public health guidance on ADHD from the CDC.

Moderate to severe binge eating disorder in adults

This is the second approved use, and it is adults only. Binge eating disorder means repeated episodes of eating unusually large amounts of food with a sense of loss of control. In trials, treatment reduced the number of binge days per week. The medication is not approved for mild binge eating, and it is not approved for bulimia or anorexia. Talking therapy, particularly cognitive behavioural therapy, remains a mainstay of care for eating disorders, and many clinicians use medication alongside it rather than instead of it.

What it is not approved for

The label carries a clear limitation of use: this is not a weight loss drug. Safety and effectiveness for treating obesity have not been established, and amphetamines used for weight loss carry serious risks. Reduced appetite and some weight loss are listed side effects, not treatment goals. If weight is the reason you are searching, that is a different conversation with a clinician, and a different set of medications.

Forms, brand names and the dosing ranges on the label

The molecule is sold as capsules, and some brand products also come as chewable tablets. The brand name most Americans recognise is Vyvanse. Generic lisdexamfetamine dimesylate capsules are also marketed by several manufacturers. Generics must meet federal standards for the same active ingredient and absorption, so the clinical difference is usually price, appearance and inactive ingredients rather than effect.

Dosing is a prescriber decision, and the numbers below are label reference points only, not instructions. According to the FDA prescribing information for the brand product, treatment for ADHD generally starts at 30 mg once daily in the morning, may be adjusted in 10 mg or 20 mg steps at weekly intervals, and does not exceed 70 mg per day. For binge eating disorder, the label describes starting at 30 mg daily, stepping up to a target range of 50 mg to 70 mg daily, with the same 70 mg ceiling.

Three practical points sit alongside those numbers. Afternoon doses are avoided because they cause trouble sleeping. Capsules may be opened and the full contents mixed into water, yogurt or orange juice, but a dose is never split across two servings. And reduced kidney function lowers the maximum dose, so kidney disease is something to raise before starting. Your prescriber may also plan periods off treatment to reassess whether it is still helping.

Side effects most people notice, and the rarer ones that matter

Side effects cluster around the stimulant effect itself: less hunger, more alertness, a faster heartbeat, a drier mouth. Most are dose related, and many settle in the first weeks. Rough frequencies below reflect what the label reports in at least five percent of trial participants.

In adults

The most commonly reported effects in adult ADHD trials were reduced appetite, insomnia, dry mouth, weight loss, irritability, increased heart rate, sweating, anxiety, nausea, diarrhoea and a jittery feeling. In binge eating disorder trials, dry mouth, insomnia, reduced appetite, faster heart rate, constipation, jitteriness and anxiety were the most frequent. A patient-facing summary of these effects is maintained by Mayo Clinic drug and supplement information.

In children and teenagers

Children reported reduced appetite, trouble sleeping, stomach pain, irritability, vomiting, nausea, weight loss, dry mouth, dizziness and faster heart rate most often. Appetite and growth deserve monitoring in this group. Stimulants can slow expected height and weight gain over long periods, so height and weight checks at follow-up visits are standard rather than optional.

Less common, more serious

Serious reactions are uncommon but well documented. They include sudden cardiac events in people with existing heart disease, stroke and heart attack in adults, new or worsening psychosis and manic episodes, new or worsening tics, and painful colour changes in fingers and toes from reduced circulation, sometimes called Raynaud phenomenon. Prolonged, painful erections have been reported with amphetamines and need urgent attention. Combining this medication with drugs that raise serotonin can trigger serotonin syndrome, a dangerous reaction involving agitation, fever, muscle stiffness and a racing heart.

Boxed warning, who should avoid it, and drug interactions

Abuse, misuse and addiction

The label opens with a boxed warning, the strongest warning the FDA uses. It states that this medication has a high potential for abuse and misuse, which can lead to substance use disorder, including addiction, and that misuse can cause overdose and death. Risk rises with higher doses and with routes the drug was never designed for, such as snorting or injecting. When people online talk about the dark side of this drug, this is the honest version of it: dependence, sleep loss, appetite loss, mood crashes as a dose wears off, and misuse potential.

Prescribers are expected to assess abuse risk before writing a prescription and to monitor during treatment. Federal regulators have updated stimulant labelling to sharpen these messages, described in an FDA safety communication on prescription stimulants. Storage matters too. Keep capsules where others cannot reach them, and never share a prescription.

Who should not take it

The label lists two contraindications. The first is known allergy or hypersensitivity to amphetamine products. The second is taking a monoamine oxidase inhibitor (MAOI) now, or within the past 14 days, because that combination can cause a hypertensive crisis, a dangerous spike in blood pressure. Beyond those, the label advises avoiding use in people with known structural heart abnormalities, cardiomyopathy, serious arrhythmias, coronary artery disease or other serious cardiac disease. Uncontrolled high blood pressure, a history of psychosis or bipolar disorder, and a history of stimulant misuse all call for careful screening first.

Interactions worth naming

Bring a full list of everything you take, including supplements. The interactions that come up most often are MAOIs, medicines that raise serotonin such as SSRI and SNRI antidepressants, triptans for migraine, tramadol and St John’s wort, other stimulants or amphetamine-containing products, decongestants such as pseudoephedrine, and tricyclic antidepressants. Products that change stomach or urine acidity can shift how much amphetamine your body holds onto, so antacids, sodium bicarbonate and high-dose vitamin C are worth mentioning. Alcohol and cannabis add their own risks. Patient guidance from MedlinePlus, produced by the National Library of Medicine, also flags that this drug can be habit forming and should never be taken in a different way or for longer than prescribed.

Pregnancy and breastfeeding

Amphetamine use during pregnancy has been linked to premature delivery, low birth weight and withdrawal symptoms in newborns. Amphetamines also pass into breast milk, and the label advises against breastfeeding during treatment. If you are pregnant, planning a pregnancy or nursing, raise it before the first prescription rather than after.

How it compares with Adderall and other options

The most common question people ask is whether this is basically Adderall. Not quite. Both are amphetamines and both sit in Schedule II, but the active ingredient and the delivery method differ. Adderall contains a mix of amphetamine salts that are active immediately. Lisdexamfetamine has to be converted in the body first, which produces a slower onset and a longer, smoother curve, and makes it harder to misuse by crushing.

If stimulants are not a good fit, non-stimulant prescription options exist for ADHD, including atomoxetine, viloxazine, guanfacine and clonidine in extended-release forms. These are not controlled substances, take longer to show an effect, and have their own side effect profiles. For binge eating disorder, this molecule is the only medication with a specific FDA approval, and structured therapy is a core part of treatment. Background on the range of ADHD treatments is available from the National Institute of Mental Health.

What lisdexamfetamine costs when you pay cash

Costs on this site are shown as US dollars per month, and two routes are tracked separately. Cash pay is what a self-paying patient pays with no insurance involved. With insurance means the plan or membership fee only, and it excludes copays and deductibles, which change by plan and state.

Across the telehealth programs we track that prescribe this molecule, the lowest recurring self-pay price is a month and the highest is a month. Those figures are the program cost, which usually buys the clinical visit, the prescription and follow-up. For a controlled substance, the medication itself is almost always dispensed by a local pharmacy and billed separately, so a program fee and a pharmacy bill are two different numbers. Advertised prices move, and introductory pricing often rises at renewal, so check the current figure before you commit.

Four things move the pharmacy side of the bill. Brand versus generic is the biggest lever, since generic capsules are typically far cheaper at cash prices. Pharmacy choice is the second, because cash prices for the same strength can differ sharply between chains and independents in the same town. Dose strength matters less than people expect, as many pharmacies price per capsule. Quantity matters more: Schedule II rules and plan limits often mean a 30-day supply at a time rather than 90 days, which removes the usual bulk saving. Drug shortages have also affected stimulant supply, and a pharmacy switch under time pressure rarely gets you the best price. The federal shortage list is published as an FDA database of current drug shortages.

A monthly number is easier to judge once you see the annual total it implies.

If you have coverage but face prior authorisation or a high deductible, it is worth comparing the plan route against paying cash outright.

Coverage for stimulants varies by plan, formulary tier and diagnosis, and quantity limits are common. No page can tell you what your plan will pay, so call the number on your card and ask about the specific strength and quantity. Our Free Savings Report shows the format we use to lay out monthly costs side by side, and other calculators sit in the Patient Cost Calculators collection.

How telehealth programs handle a Schedule II stimulant

Stimulant prescribing online is not like ordering a skincare cream. Schedule II prescriptions cannot be refilled, so each fill needs a fresh prescription, and prescriptions have limited validity periods that vary by state. The scheduling framework itself is described by the Drug Enforcement Administration.

This is also where the widely discussed 28 day question comes from. There is no single federal rule that says 28 days. What happens in practice is a stack of limits: the no-refill rule, a 30-day supply limit written into many plans, insurer and pharmacy policies that block an early fill until most of the previous supply should be gone, and state prescription monitoring programs that flag overlapping fills. The result feels like a rule even though it is really several policies pointing the same way.

Programs differ in ways worth comparing before you sign up. Some prescribe controlled stimulants, others decline them entirely and only manage non-stimulant options. Some require a video visit with a clinician licensed in your state, others build in an in-person evaluation. Federal rules for prescribing controlled substances by telemedicine have changed repeatedly since 2020 and remain subject to state licensure requirements on top, so what a platform can legally do depends on where you live. Ask directly whether monthly re-prescribing is included, how quickly a prescription is sent when your pharmacy is out of stock, and whether follow-up visits cost extra.

Patient experiences vary widely, which is why people search Reddit for them. On this site, reviews are attached to the program rather than the molecule, and they are moderated. The Telehealth Provider Directory lists programs by condition, the Scoring Methodology page explains what each provider score covers, and our Telehealth Analysis section digs into how these programs behave in practice.

Questions to ask, and when to get urgent help

Bring a short list to the first appointment. Useful questions include: what heart and blood pressure checks do I need before starting and during treatment; do my family history or existing conditions rule out a stimulant; how will we monitor sleep, appetite, weight and mood; what should I do if a dose wears off badly in the afternoon; what is the plan if this does not work; and how do we reassess whether I still need it. For a child, add growth tracking and school communication. If you have a history of substance use, say so plainly, because it changes the safest plan rather than closing the door.

Some symptoms need immediate care rather than a message to your clinician. Get emergency help for chest pain, trouble breathing, fainting, signs of stroke such as sudden weakness, slurred speech or facial drooping, or a seizure. Call your prescriber urgently for new hallucinations, paranoia, unusually elevated or agitated mood, thoughts of self-harm, fingers or toes turning white, blue or numb, unexplained wounds on the fingers, a prolonged painful erection, or a combination of agitation, fever, sweating, muscle stiffness and a racing heart, which can signal serotonin syndrome.

Authoritative sources

• Current US labelling for lisdexamfetamine products, searchable at DailyMed, from t